Early achievement of significant weight loss with naltrexone-bupropion is associated with additional weight loss and improved glycemic control at 1 year in patients with type 2 diabetes
Early achievement of significant weight loss with naltrexone-bupropion is associated with additional weight loss and improved glycemic control at 1 year in patients with type 2 diabetes